| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Insulin-Secreting Cells | 80 | 2023 | 901 | 13.090 |
Why?
|
| Islets of Langerhans | 162 | 2024 | 1341 | 11.950 |
Why?
|
| Pancreatic Ducts | 25 | 2021 | 329 | 4.210 |
Why?
|
| Islets of Langerhans Transplantation | 68 | 2024 | 740 | 3.590 |
Why?
|
| Pancreas | 46 | 2017 | 1691 | 3.330 |
Why?
|
| Diabetes Mellitus, Type 1 | 33 | 2023 | 3415 | 2.240 |
Why?
|
| Insulin | 111 | 2024 | 6596 | 2.210 |
Why?
|
| Diabetes Mellitus, Experimental | 58 | 2024 | 1119 | 2.080 |
Why?
|
| Regeneration | 25 | 2017 | 1511 | 1.920 |
Why?
|
| Glucose | 41 | 2023 | 4346 | 1.860 |
Why?
|
| Maf Transcription Factors, Large | 9 | 2018 | 21 | 1.860 |
Why?
|
| Insulin Resistance | 21 | 2023 | 3963 | 1.690 |
Why?
|
| Cell Differentiation | 42 | 2023 | 11528 | 1.380 |
Why?
|
| Triiodothyronine | 3 | 2018 | 493 | 1.340 |
Why?
|
| Diabetes Mellitus, Type 2 | 39 | 2023 | 12148 | 1.330 |
Why?
|
| Glucagon | 28 | 2023 | 532 | 1.310 |
Why?
|
| Receptors, Glucagon | 5 | 2022 | 90 | 1.220 |
Why?
|
| Stem Cells | 21 | 2023 | 3522 | 1.220 |
Why?
|
| Diabetes Mellitus | 22 | 2023 | 5840 | 1.160 |
Why?
|
| Glucagon-Secreting Cells | 2 | 2023 | 42 | 0.980 |
Why?
|
| Rats | 107 | 2024 | 23742 | 0.980 |
Why?
|
| Hyperglycemia | 25 | 2023 | 1376 | 0.950 |
Why?
|
| Animals | 233 | 2024 | 168459 | 0.820 |
Why?
|
| Trans-Activators | 15 | 2016 | 2856 | 0.760 |
Why?
|
| Pancreatectomy | 29 | 2020 | 811 | 0.730 |
Why?
|
| Homeodomain Proteins | 16 | 2016 | 2416 | 0.710 |
Why?
|
| Tissue Culture Techniques | 2 | 2018 | 290 | 0.680 |
Why?
|
| Rats, Sprague-Dawley | 44 | 2018 | 8181 | 0.640 |
Why?
|
| Cell Size | 7 | 2013 | 624 | 0.640 |
Why?
|
| Embryonic Stem Cells | 5 | 2015 | 1263 | 0.630 |
Why?
|
| Cell Division | 31 | 2010 | 4465 | 0.630 |
Why?
|
| Mice | 121 | 2024 | 81525 | 0.610 |
Why?
|
| Hypoglycemia | 4 | 2023 | 883 | 0.610 |
Why?
|
| Hepatocyte Nuclear Factor 1-beta | 2 | 2018 | 92 | 0.600 |
Why?
|
| Organoids | 3 | 2018 | 740 | 0.600 |
Why?
|
| Carbonic Anhydrase II | 2 | 2008 | 21 | 0.600 |
Why?
|
| Blood Glucose | 63 | 2023 | 6391 | 0.590 |
Why?
|
| SOX9 Transcription Factor | 1 | 2018 | 145 | 0.570 |
Why?
|
| Cell Transdifferentiation | 4 | 2013 | 185 | 0.530 |
Why?
|
| Pancreas, Exocrine | 3 | 2015 | 48 | 0.530 |
Why?
|
| Animals, Newborn | 23 | 2014 | 2678 | 0.520 |
Why?
|
| Cell Growth Processes | 2 | 2013 | 384 | 0.490 |
Why?
|
| Venoms | 6 | 2013 | 94 | 0.490 |
Why?
|
| Cell Proliferation | 16 | 2018 | 10445 | 0.480 |
Why?
|
| Glucagon-Like Peptide 1 | 6 | 2013 | 364 | 0.470 |
Why?
|
| Incretins | 2 | 2014 | 99 | 0.450 |
Why?
|
| Cell Dedifferentiation | 1 | 2013 | 122 | 0.430 |
Why?
|
| Proto-Oncogene Proteins c-maf | 1 | 2013 | 69 | 0.420 |
Why?
|
| Matrix Metalloproteinase 2 | 3 | 2016 | 459 | 0.420 |
Why?
|
| Epithelial Cells | 10 | 2018 | 3673 | 0.380 |
Why?
|
| Apoptosis | 19 | 2022 | 9486 | 0.370 |
Why?
|
| Microdissection | 6 | 2011 | 151 | 0.360 |
Why?
|
| Mice, Inbred C57BL | 31 | 2019 | 22169 | 0.360 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 15 | 2015 | 4575 | 0.360 |
Why?
|
| Tissue Engineering | 5 | 2013 | 1868 | 0.360 |
Why?
|
| Stem Cell Transplantation | 3 | 2010 | 1600 | 0.360 |
Why?
|
| Keratin-19 | 1 | 2010 | 33 | 0.350 |
Why?
|
| Pulmonary Surfactant-Associated Protein D | 1 | 2010 | 48 | 0.350 |
Why?
|
| Cell Culture Techniques | 9 | 2014 | 1667 | 0.330 |
Why?
|
| Humans | 117 | 2024 | 761504 | 0.330 |
Why?
|
| beta-Galactosidase | 3 | 2008 | 574 | 0.320 |
Why?
|
| Streptozocin | 10 | 2013 | 194 | 0.320 |
Why?
|
| Mice, Transgenic | 21 | 2015 | 9539 | 0.310 |
Why?
|
| Multipotent Stem Cells | 2 | 2013 | 200 | 0.310 |
Why?
|
| Gene Expression Regulation, Developmental | 9 | 2017 | 3612 | 0.310 |
Why?
|
| Pyrrolidines | 1 | 2010 | 338 | 0.310 |
Why?
|
| RNA, Messenger | 27 | 2023 | 12795 | 0.300 |
Why?
|
| Protein Transport | 5 | 2013 | 1967 | 0.290 |
Why?
|
| Peptides | 9 | 2023 | 4358 | 0.290 |
Why?
|
| Receptors, Gastrointestinal Hormone | 1 | 2007 | 39 | 0.290 |
Why?
|
| Dipeptidyl-Peptidase IV Inhibitors | 2 | 2013 | 311 | 0.280 |
Why?
|
| Monosaccharide Transport Proteins | 9 | 2002 | 436 | 0.280 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 9 | 2015 | 1136 | 0.280 |
Why?
|
| Green Fluorescent Proteins | 6 | 2017 | 2065 | 0.270 |
Why?
|
| Cells, Cultured | 20 | 2019 | 18965 | 0.270 |
Why?
|
| Transplantation, Heterologous | 13 | 2010 | 2385 | 0.270 |
Why?
|
| Cyclin A | 2 | 2005 | 60 | 0.260 |
Why?
|
| Cell Separation | 6 | 2010 | 1720 | 0.260 |
Why?
|
| Cell Lineage | 7 | 2016 | 2555 | 0.260 |
Why?
|
| MafB Transcription Factor | 3 | 2013 | 25 | 0.260 |
Why?
|
| Cell Count | 12 | 2010 | 1835 | 0.250 |
Why?
|
| Cell Line | 10 | 2011 | 15601 | 0.250 |
Why?
|
| Endosomes | 2 | 2005 | 522 | 0.250 |
Why?
|
| Genes, Reporter | 7 | 2013 | 1529 | 0.250 |
Why?
|
| Transcription Factors | 15 | 2015 | 12128 | 0.250 |
Why?
|
| Gene Expression Regulation | 19 | 2014 | 11903 | 0.250 |
Why?
|
| Graft Survival | 10 | 2024 | 3819 | 0.240 |
Why?
|
| Oxidative Stress | 5 | 2009 | 3113 | 0.240 |
Why?
|
| Receptors, Thyroid Hormone | 2 | 2018 | 199 | 0.240 |
Why?
|
| Nitriles | 1 | 2010 | 971 | 0.240 |
Why?
|
| Genes, myc | 3 | 2002 | 390 | 0.240 |
Why?
|
| Somatostatin | 16 | 2009 | 447 | 0.240 |
Why?
|
| Cell Nucleus | 5 | 2023 | 2909 | 0.240 |
Why?
|
| Endocrine Cells | 3 | 2015 | 9 | 0.230 |
Why?
|
| Mice, Inbred NOD | 10 | 2022 | 1827 | 0.210 |
Why?
|
| Gels | 1 | 2024 | 420 | 0.210 |
Why?
|
| Endocytosis | 3 | 2005 | 957 | 0.210 |
Why?
|
| Flow Cytometry | 5 | 2019 | 5869 | 0.200 |
Why?
|
| Body Weight | 21 | 2019 | 4618 | 0.200 |
Why?
|
| Stress, Physiological | 4 | 2022 | 1403 | 0.200 |
Why?
|
| Male | 115 | 2024 | 360804 | 0.200 |
Why?
|
| DNA-Binding Proteins | 10 | 2009 | 9606 | 0.200 |
Why?
|
| Alginates | 6 | 2011 | 248 | 0.200 |
Why?
|
| Nerve Tissue Proteins | 11 | 2015 | 4414 | 0.200 |
Why?
|
| Rats, Inbred Lew | 13 | 2020 | 1157 | 0.180 |
Why?
|
| Keratins | 4 | 2016 | 498 | 0.180 |
Why?
|
| Culture Techniques | 2 | 2001 | 531 | 0.180 |
Why?
|
| Fetal Tissue Transplantation | 2 | 1998 | 138 | 0.180 |
Why?
|
| Iodide Peroxidase | 2 | 2013 | 294 | 0.180 |
Why?
|
| Collagen Type I | 1 | 2024 | 616 | 0.180 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 2 | 2018 | 698 | 0.170 |
Why?
|
| Cadaver | 3 | 2013 | 1358 | 0.170 |
Why?
|
| Transduction, Genetic | 4 | 2009 | 903 | 0.170 |
Why?
|
| Cell Aggregation | 6 | 2010 | 239 | 0.170 |
Why?
|
| Cell Transplantation | 3 | 2012 | 472 | 0.170 |
Why?
|
| Promoter Regions, Genetic | 9 | 2013 | 5789 | 0.170 |
Why?
|
| Gene Expression Profiling | 11 | 2017 | 9420 | 0.170 |
Why?
|
| Rats, Inbred Strains | 17 | 1991 | 2088 | 0.160 |
Why?
|
| Models, Biological | 12 | 2017 | 9469 | 0.160 |
Why?
|
| Signal Transduction | 9 | 2022 | 23445 | 0.160 |
Why?
|
| Swine | 14 | 2014 | 5915 | 0.160 |
Why?
|
| Integrin alphaV | 1 | 2018 | 54 | 0.150 |
Why?
|
| Down-Regulation | 4 | 2020 | 2919 | 0.150 |
Why?
|
| Cell Death | 7 | 2013 | 1678 | 0.150 |
Why?
|
| Hemolytic Plaque Technique | 1 | 2017 | 60 | 0.150 |
Why?
|
| Remission Induction | 1 | 2023 | 2396 | 0.140 |
Why?
|
| Staining and Labeling | 3 | 2014 | 1085 | 0.140 |
Why?
|
| Phagocytosis | 2 | 2022 | 1528 | 0.140 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 1999 | 426 | 0.140 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 6 | 2011 | 3778 | 0.140 |
Why?
|
| Liver | 11 | 2011 | 7529 | 0.140 |
Why?
|
| Adenoviridae | 6 | 2009 | 1084 | 0.140 |
Why?
|
| Capsules | 7 | 2011 | 191 | 0.130 |
Why?
|
| Pancreatic Polypeptide | 8 | 2013 | 34 | 0.130 |
Why?
|
| Gastrins | 4 | 2013 | 74 | 0.130 |
Why?
|
| Carbonic Anhydrases | 1 | 2016 | 108 | 0.130 |
Why?
|
| Ki-67 Antigen | 2 | 2014 | 629 | 0.130 |
Why?
|
| Cell Survival | 8 | 2013 | 5791 | 0.130 |
Why?
|
| Glucose Tolerance Test | 15 | 2011 | 1178 | 0.120 |
Why?
|
| Up-Regulation | 2 | 2018 | 4124 | 0.120 |
Why?
|
| Mice, Nude | 10 | 2005 | 3615 | 0.120 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2007 | 1651 | 0.120 |
Why?
|
| Unfolded Protein Response | 1 | 2017 | 234 | 0.120 |
Why?
|
| NAD | 1 | 1999 | 614 | 0.120 |
Why?
|
| Glucose Transporter Type 2 | 6 | 2015 | 61 | 0.120 |
Why?
|
| Gene Expression | 13 | 2020 | 7581 | 0.120 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2017 | 379 | 0.120 |
Why?
|
| Glucose Clamp Technique | 3 | 2019 | 263 | 0.120 |
Why?
|
| Angiopoietins | 1 | 2014 | 85 | 0.120 |
Why?
|
| Immunohistochemistry | 9 | 2015 | 11076 | 0.120 |
Why?
|
| Time Factors | 24 | 2019 | 39967 | 0.120 |
Why?
|
| Pancreatic Diseases | 2 | 2013 | 343 | 0.110 |
Why?
|
| Aging | 8 | 2017 | 8708 | 0.110 |
Why?
|
| HeLa Cells | 6 | 2006 | 3093 | 0.110 |
Why?
|
| Adult | 22 | 2018 | 221177 | 0.110 |
Why?
|
| Aniline Compounds | 1 | 2019 | 1069 | 0.110 |
Why?
|
| Epithelium | 2 | 2015 | 1603 | 0.110 |
Why?
|
| Disease Progression | 5 | 2021 | 13506 | 0.110 |
Why?
|
| Protein Precursors | 3 | 2005 | 1132 | 0.110 |
Why?
|
| Tumor Necrosis Factors | 1 | 2013 | 107 | 0.110 |
Why?
|
| Microscopy, Electron | 5 | 2010 | 2561 | 0.110 |
Why?
|
| Endothelial Growth Factors | 3 | 2001 | 673 | 0.110 |
Why?
|
| Hormones | 2 | 2016 | 869 | 0.110 |
Why?
|
| Recombinant Proteins | 7 | 2013 | 6534 | 0.110 |
Why?
|
| Cell Polarity | 1 | 2016 | 637 | 0.110 |
Why?
|
| Biomedical Research | 1 | 2008 | 3429 | 0.110 |
Why?
|
| Embryonic and Fetal Development | 1 | 1993 | 420 | 0.110 |
Why?
|
| Gene Expression Regulation, Enzymologic | 2 | 2009 | 1171 | 0.110 |
Why?
|
| Rats, Zucker | 5 | 2013 | 131 | 0.100 |
Why?
|
| Lymphokines | 3 | 2001 | 927 | 0.100 |
Why?
|
| Arginine | 9 | 2005 | 934 | 0.100 |
Why?
|
| Mice, Inbred ICR | 2 | 2010 | 364 | 0.100 |
Why?
|
| Mice, Inbred Strains | 12 | 2006 | 1762 | 0.100 |
Why?
|
| I-kappa B Kinase | 1 | 2013 | 250 | 0.100 |
Why?
|
| Molecular Chaperones | 2 | 2001 | 754 | 0.100 |
Why?
|
| Pancreas Transplantation | 2 | 2003 | 197 | 0.100 |
Why?
|
| Protein Kinase C | 3 | 2007 | 1202 | 0.090 |
Why?
|
| Glycerolphosphate Dehydrogenase | 1 | 2011 | 37 | 0.090 |
Why?
|
| C-Peptide | 5 | 2019 | 440 | 0.090 |
Why?
|
| Chromatin | 1 | 2023 | 2960 | 0.090 |
Why?
|
| Female | 41 | 2019 | 392644 | 0.090 |
Why?
|
| Transcription, Genetic | 4 | 2006 | 7594 | 0.090 |
Why?
|
| Malate Dehydrogenase | 1 | 2011 | 40 | 0.090 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2016 | 1076 | 0.090 |
Why?
|
| Dithizone | 1 | 2010 | 2 | 0.090 |
Why?
|
| Hepatocyte Nuclear Factor 6 | 1 | 2010 | 9 | 0.090 |
Why?
|
| Lasers | 3 | 2010 | 952 | 0.090 |
Why?
|
| Polymerase Chain Reaction | 6 | 2007 | 6075 | 0.090 |
Why?
|
| Cyclic AMP Response Element Modulator | 3 | 2005 | 88 | 0.090 |
Why?
|
| Expressed Sequence Tags | 1 | 2011 | 250 | 0.090 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2017 | 1141 | 0.090 |
Why?
|
| Adaptation, Physiological | 5 | 2002 | 1301 | 0.090 |
Why?
|
| Paired Box Transcription Factors | 2 | 2007 | 206 | 0.090 |
Why?
|
| Protein Denaturation | 1 | 2010 | 242 | 0.090 |
Why?
|
| Amyloid | 3 | 2008 | 841 | 0.090 |
Why?
|
| Calcium-Binding Proteins | 3 | 2008 | 1069 | 0.090 |
Why?
|
| Glucokinase | 4 | 2003 | 102 | 0.090 |
Why?
|
| Isoenzymes | 2 | 2007 | 1687 | 0.090 |
Why?
|
| Organ Size | 7 | 2002 | 2254 | 0.090 |
Why?
|
| Peptide Fragments | 4 | 2005 | 5112 | 0.080 |
Why?
|
| Silicon | 1 | 2010 | 142 | 0.080 |
Why?
|
| Blotting, Western | 4 | 2010 | 5035 | 0.080 |
Why?
|
| Sulfonamides | 1 | 2019 | 1978 | 0.080 |
Why?
|
| Ligands | 1 | 2016 | 3272 | 0.080 |
Why?
|
| Models, Animal | 4 | 2004 | 2112 | 0.080 |
Why?
|
| Antigens, Differentiation | 2 | 2004 | 910 | 0.080 |
Why?
|
| Aspartate Aminotransferases | 1 | 2011 | 416 | 0.080 |
Why?
|
| Pancreatic Neoplasms | 2 | 2023 | 5368 | 0.080 |
Why?
|
| Autopsy | 1 | 2013 | 1008 | 0.080 |
Why?
|
| Cytochrome-B(5) Reductase | 1 | 2008 | 17 | 0.080 |
Why?
|
| Postpartum Period | 1 | 1995 | 1173 | 0.080 |
Why?
|
| Growth Substances | 2 | 2001 | 768 | 0.080 |
Why?
|
| Transforming Growth Factor beta | 3 | 2004 | 1961 | 0.080 |
Why?
|
| Mitosis | 4 | 2002 | 1187 | 0.080 |
Why?
|
| NF-kappa B | 3 | 2013 | 2490 | 0.080 |
Why?
|
| Middle Aged | 16 | 2019 | 220895 | 0.080 |
Why?
|
| Microscopy | 2 | 2010 | 903 | 0.080 |
Why?
|
| Transcriptional Activation | 3 | 2004 | 1756 | 0.080 |
Why?
|
| Gene Deletion | 1 | 2016 | 2665 | 0.080 |
Why?
|
| Random Allocation | 1 | 2013 | 2395 | 0.080 |
Why?
|
| Ubiquitin Thiolesterase | 2 | 2008 | 455 | 0.080 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 2 | 2009 | 687 | 0.070 |
Why?
|
| Protein Isoforms | 1 | 2013 | 1699 | 0.070 |
Why?
|
| DNA Primers | 7 | 2009 | 2819 | 0.070 |
Why?
|
| Immunomodulation | 1 | 2012 | 549 | 0.070 |
Why?
|
| alpha 1-Antitrypsin | 1 | 2008 | 167 | 0.070 |
Why?
|
| Phosphoproteins | 4 | 2007 | 2448 | 0.070 |
Why?
|
| Transgenes | 2 | 2008 | 1010 | 0.070 |
Why?
|
| Epidermal Growth Factor | 2 | 2013 | 701 | 0.070 |
Why?
|
| Bile Ducts, Intrahepatic | 1 | 2009 | 296 | 0.070 |
Why?
|
| Transfection | 7 | 2006 | 5774 | 0.070 |
Why?
|
| Cloning, Molecular | 4 | 2009 | 4174 | 0.070 |
Why?
|
| Transforming Growth Factor alpha | 2 | 2000 | 135 | 0.070 |
Why?
|
| CA-19-9 Antigen | 1 | 2007 | 106 | 0.070 |
Why?
|
| src-Family Kinases | 1 | 2009 | 535 | 0.070 |
Why?
|
| Palmitic Acid | 2 | 2022 | 149 | 0.070 |
Why?
|
| Repressor Proteins | 3 | 2007 | 2986 | 0.070 |
Why?
|
| Animals, Suckling | 1 | 2006 | 69 | 0.070 |
Why?
|
| RNA | 5 | 2009 | 2726 | 0.070 |
Why?
|
| Forkhead Transcription Factors | 1 | 2013 | 1616 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-myc | 2 | 2002 | 988 | 0.070 |
Why?
|
| Protein Tyrosine Phosphatases | 2 | 2007 | 457 | 0.070 |
Why?
|
| Glucose Intolerance | 4 | 2007 | 575 | 0.070 |
Why?
|
| Aged | 12 | 2019 | 169289 | 0.070 |
Why?
|
| Awards and Prizes | 1 | 2010 | 360 | 0.070 |
Why?
|
| Cell Communication | 3 | 1990 | 1657 | 0.070 |
Why?
|
| Embryo, Mammalian | 3 | 2007 | 1675 | 0.060 |
Why?
|
| Disease Models, Animal | 12 | 2020 | 18252 | 0.060 |
Why?
|
| Vimentin | 2 | 2004 | 255 | 0.060 |
Why?
|
| Transplantation, Heterotopic | 5 | 1997 | 174 | 0.060 |
Why?
|
| Recombinant Fusion Proteins | 5 | 2010 | 3734 | 0.060 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 2 | 2002 | 5671 | 0.060 |
Why?
|
| Insulin-Like Growth Factor I | 2 | 2001 | 1934 | 0.060 |
Why?
|
| DNA | 11 | 2011 | 7212 | 0.060 |
Why?
|
| Neurons | 1 | 2004 | 9463 | 0.060 |
Why?
|
| Oxygen | 3 | 2010 | 4227 | 0.060 |
Why?
|
| Obesity | 7 | 2012 | 12947 | 0.060 |
Why?
|
| Immunoconjugates | 2 | 2004 | 954 | 0.060 |
Why?
|
| Dexamethasone | 5 | 2007 | 1948 | 0.060 |
Why?
|
| Eye Proteins | 1 | 2007 | 633 | 0.060 |
Why?
|
| Models, Theoretical | 2 | 1996 | 3575 | 0.060 |
Why?
|
| Mice, Knockout | 9 | 2013 | 14414 | 0.060 |
Why?
|
| Hepatocyte Growth Factor | 2 | 2007 | 270 | 0.060 |
Why?
|
| Cyclic AMP | 2 | 2004 | 1463 | 0.050 |
Why?
|
| Korea | 1 | 2003 | 98 | 0.050 |
Why?
|
| Hepatocytes | 2 | 2008 | 1233 | 0.050 |
Why?
|
| Cattle | 5 | 2001 | 3849 | 0.050 |
Why?
|
| Kidney Glomerulus | 1 | 2005 | 568 | 0.050 |
Why?
|
| Stearic Acids | 1 | 2022 | 56 | 0.050 |
Why?
|
| Neovascularization, Physiologic | 2 | 2000 | 1349 | 0.050 |
Why?
|
| Oxidoreductases | 2 | 2002 | 413 | 0.050 |
Why?
|
| Immunocompetence | 1 | 2003 | 138 | 0.050 |
Why?
|
| Reference Values | 8 | 2001 | 4920 | 0.050 |
Why?
|
| Fatty Acids | 2 | 2008 | 1808 | 0.050 |
Why?
|
| Genetic Vectors | 4 | 2006 | 3395 | 0.050 |
Why?
|
| Macrophages, Peritoneal | 1 | 2003 | 238 | 0.050 |
Why?
|
| Metabolic Diseases | 1 | 2009 | 683 | 0.050 |
Why?
|
| Bariatric Surgery | 1 | 2012 | 992 | 0.050 |
Why?
|
| Embryo, Nonmammalian | 1 | 2005 | 906 | 0.050 |
Why?
|
| Adolescent | 6 | 2019 | 88319 | 0.050 |
Why?
|
| Mitogen-Activated Protein Kinases | 2 | 2007 | 1246 | 0.050 |
Why?
|
| Amyloidosis | 1 | 2008 | 817 | 0.050 |
Why?
|
| Lentivirus | 1 | 2004 | 508 | 0.050 |
Why?
|
| Hexuronic Acids | 3 | 2011 | 145 | 0.050 |
Why?
|
| Hexosamines | 1 | 2001 | 40 | 0.050 |
Why?
|
| Glucuronic Acid | 3 | 2011 | 150 | 0.050 |
Why?
|
| Autophagy | 1 | 2009 | 1326 | 0.050 |
Why?
|
| Transplantation, Isogeneic | 6 | 1998 | 248 | 0.050 |
Why?
|
| Spleen | 2 | 2006 | 2295 | 0.050 |
Why?
|
| Receptor, Insulin | 3 | 2007 | 835 | 0.050 |
Why?
|
| Autoantibodies | 3 | 2019 | 2116 | 0.050 |
Why?
|
| Histocytochemistry | 3 | 2006 | 698 | 0.050 |
Why?
|
| Kidney | 6 | 2006 | 7048 | 0.050 |
Why?
|
| Ubiquitin | 1 | 2006 | 839 | 0.050 |
Why?
|
| Receptors, Cell Surface | 2 | 2008 | 2822 | 0.050 |
Why?
|
| Eating | 4 | 2001 | 1539 | 0.050 |
Why?
|
| Sex Characteristics | 2 | 2010 | 2639 | 0.050 |
Why?
|
| Myelin P2 Protein | 1 | 2000 | 20 | 0.050 |
Why?
|
| Lysine | 1 | 2005 | 993 | 0.050 |
Why?
|
| Fats | 1 | 2001 | 99 | 0.050 |
Why?
|
| Bone Marrow Transplantation | 1 | 2008 | 2693 | 0.040 |
Why?
|
| Phosphatidylserines | 1 | 2022 | 188 | 0.040 |
Why?
|
| Diffusion Chambers, Culture | 2 | 1998 | 49 | 0.040 |
Why?
|
| Muscle Proteins | 2 | 1996 | 1154 | 0.040 |
Why?
|
| History, 20th Century | 1 | 2008 | 2767 | 0.040 |
Why?
|
| Microcirculation | 3 | 1999 | 1273 | 0.040 |
Why?
|
| Graft Rejection | 3 | 2006 | 4445 | 0.040 |
Why?
|
| Neoplasm Proteins | 2 | 2004 | 3617 | 0.040 |
Why?
|
| Inhibins | 1 | 2001 | 210 | 0.040 |
Why?
|
| Young Adult | 3 | 2017 | 59243 | 0.040 |
Why?
|
| Retroviridae | 1 | 2003 | 850 | 0.040 |
Why?
|
| Rabbits | 2 | 2006 | 4772 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 1 | 2022 | 368 | 0.040 |
Why?
|
| Endoplasmic Reticulum | 4 | 2010 | 1134 | 0.040 |
Why?
|
| Receptors, Growth Factor | 1 | 2001 | 326 | 0.040 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2012 | 1860 | 0.040 |
Why?
|
| Phagocytes | 1 | 2022 | 295 | 0.040 |
Why?
|
| Laminin | 3 | 2010 | 408 | 0.040 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2001 | 613 | 0.040 |
Why?
|
| Morphogenesis | 2 | 2001 | 741 | 0.040 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2006 | 1320 | 0.040 |
Why?
|
| Fructose | 1 | 2001 | 288 | 0.040 |
Why?
|
| Insulin Antibodies | 2 | 1989 | 28 | 0.040 |
Why?
|
| Insulin Receptor Substrate Proteins | 4 | 2007 | 557 | 0.040 |
Why?
|
| Receptors, Cholecystokinin | 1 | 1999 | 18 | 0.040 |
Why?
|
| Activins | 1 | 2001 | 210 | 0.040 |
Why?
|
| Electrochemistry | 1 | 1999 | 145 | 0.040 |
Why?
|
| Urokinase-Type Plasminogen Activator | 1 | 2000 | 325 | 0.040 |
Why?
|
| Pituitary Gland, Anterior | 1 | 1999 | 142 | 0.040 |
Why?
|
| Subtilisins | 1 | 1999 | 81 | 0.040 |
Why?
|
| Adenoviridae Infections | 1 | 1999 | 93 | 0.040 |
Why?
|
| HLA-A Antigens | 1 | 2019 | 223 | 0.040 |
Why?
|
| Dietary Fats | 1 | 2007 | 1995 | 0.040 |
Why?
|
| Multifactorial Inheritance | 1 | 2007 | 1387 | 0.040 |
Why?
|
| Mice, Inbred BALB C | 5 | 2010 | 6216 | 0.040 |
Why?
|
| Cell Membrane | 1 | 1988 | 3688 | 0.040 |
Why?
|
| Pancreas, Artificial | 1 | 1999 | 54 | 0.040 |
Why?
|
| Kinetics | 4 | 2010 | 6374 | 0.040 |
Why?
|
| HLA-DR Antigens | 2 | 2010 | 602 | 0.040 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2008 | 2803 | 0.040 |
Why?
|
| Diffusion | 3 | 2011 | 814 | 0.040 |
Why?
|
| Tissue Donors | 2 | 2010 | 2331 | 0.040 |
Why?
|
| Diabetic Nephropathies | 1 | 2005 | 973 | 0.040 |
Why?
|
| Luminescent Proteins | 1 | 2001 | 837 | 0.040 |
Why?
|
| Corticosterone | 1 | 1999 | 305 | 0.040 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 2000 | 592 | 0.040 |
Why?
|
| Pituitary Hormones | 1 | 1999 | 182 | 0.040 |
Why?
|
| Tumor Cells, Cultured | 2 | 2003 | 6132 | 0.040 |
Why?
|
| Homeostasis | 4 | 2001 | 3323 | 0.040 |
Why?
|
| Cushing Syndrome | 1 | 1999 | 241 | 0.040 |
Why?
|
| Heat-Shock Proteins | 1 | 2001 | 795 | 0.040 |
Why?
|
| Muscles | 3 | 2011 | 1576 | 0.040 |
Why?
|
| Hyperplasia | 3 | 2005 | 1152 | 0.040 |
Why?
|
| Adrenocorticotropic Hormone | 1 | 1999 | 618 | 0.040 |
Why?
|
| Gastric Bypass | 1 | 2005 | 818 | 0.030 |
Why?
|
| Luciferases | 2 | 2009 | 714 | 0.030 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2001 | 829 | 0.030 |
Why?
|
| Tissue and Organ Harvesting | 1 | 2000 | 373 | 0.030 |
Why?
|
| Dietary Carbohydrates | 1 | 2001 | 891 | 0.030 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2010 | 3080 | 0.030 |
Why?
|
| Food, Formulated | 2 | 2001 | 101 | 0.030 |
Why?
|
| Hypoglycemic Agents | 3 | 2008 | 3085 | 0.030 |
Why?
|
| Autoimmunity | 2 | 2007 | 1356 | 0.030 |
Why?
|
| Immunoenzyme Techniques | 5 | 1994 | 1705 | 0.030 |
Why?
|
| Base Sequence | 5 | 2006 | 12441 | 0.030 |
Why?
|
| Pituitary-Adrenal System | 1 | 1999 | 552 | 0.030 |
Why?
|
| Inflammation | 3 | 2017 | 10773 | 0.030 |
Why?
|
| Hydrogels | 1 | 2001 | 720 | 0.030 |
Why?
|
| Clusterin | 1 | 1995 | 71 | 0.030 |
Why?
|
| Hypertrophy | 2 | 2005 | 561 | 0.030 |
Why?
|
| Amino Acid Sequence | 2 | 2005 | 13446 | 0.030 |
Why?
|
| Muscle, Skeletal | 4 | 2001 | 4948 | 0.030 |
Why?
|
| Endocrine System | 1 | 2015 | 114 | 0.030 |
Why?
|
| Lipid Metabolism | 2 | 2000 | 1902 | 0.030 |
Why?
|
| Postmortem Changes | 1 | 2014 | 119 | 0.030 |
Why?
|
| Microscopy, Confocal | 3 | 2009 | 1971 | 0.030 |
Why?
|
| Adipose Tissue | 5 | 2011 | 3312 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 3 | 1998 | 2469 | 0.030 |
Why?
|
| Molecular Sequence Data | 2 | 2005 | 17635 | 0.030 |
Why?
|
| Vascular Endothelial Growth Factors | 3 | 2001 | 748 | 0.030 |
Why?
|
| Immunosuppressive Agents | 2 | 2004 | 4174 | 0.030 |
Why?
|
| Protein Biosynthesis | 1 | 2001 | 2113 | 0.030 |
Why?
|
| Salicylic Acid | 1 | 2013 | 62 | 0.030 |
Why?
|
| Brain Death | 1 | 2017 | 357 | 0.030 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2001 | 1626 | 0.030 |
Why?
|
| Mice, SCID | 2 | 2010 | 2626 | 0.030 |
Why?
|
| Diet | 1 | 2011 | 8075 | 0.030 |
Why?
|
| Cell Line, Transformed | 2 | 1998 | 867 | 0.030 |
Why?
|
| Pregnancy | 5 | 2015 | 29874 | 0.030 |
Why?
|
| Genetic Engineering | 1 | 1998 | 933 | 0.030 |
Why?
|
| Ligation | 1 | 2013 | 448 | 0.030 |
Why?
|
| Proteoglycans | 2 | 2010 | 803 | 0.030 |
Why?
|
| Proteins | 4 | 2002 | 6032 | 0.030 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2022 | 2917 | 0.020 |
Why?
|
| Age of Onset | 2 | 2010 | 3305 | 0.020 |
Why?
|
| Energy Metabolism | 1 | 2003 | 2882 | 0.020 |
Why?
|
| Sulfur Radioisotopes | 1 | 1991 | 113 | 0.020 |
Why?
|
| 1-Methyl-3-isobutylxanthine | 3 | 1986 | 100 | 0.020 |
Why?
|
| Hyperinsulinism | 2 | 2010 | 400 | 0.020 |
Why?
|
| Triglycerides | 2 | 2014 | 2461 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 4 | 2006 | 36426 | 0.020 |
Why?
|
| Immunologic Techniques | 2 | 1996 | 212 | 0.020 |
Why?
|
| Phylogeny | 1 | 1979 | 2811 | 0.020 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2001 | 3769 | 0.020 |
Why?
|
| Octoxynol | 1 | 2011 | 77 | 0.020 |
Why?
|
| Vanadium | 1 | 1991 | 54 | 0.020 |
Why?
|
| Lactate Dehydrogenases | 1 | 2010 | 26 | 0.020 |
Why?
|
| Organ Culture Techniques | 2 | 2005 | 794 | 0.020 |
Why?
|
| Transplantation, Homologous | 3 | 2007 | 4806 | 0.020 |
Why?
|
| DNA Damage | 1 | 2021 | 2446 | 0.020 |
Why?
|
| Prediabetic State | 3 | 1992 | 545 | 0.020 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2013 | 585 | 0.020 |
Why?
|
| Numismatics | 1 | 2010 | 16 | 0.020 |
Why?
|
| Mutagenesis | 2 | 2007 | 1232 | 0.020 |
Why?
|
| Monocarboxylic Acid Transporters | 1 | 2010 | 80 | 0.020 |
Why?
|
| Species Specificity | 1 | 1995 | 2414 | 0.020 |
Why?
|
| Phlorhizin | 2 | 2001 | 37 | 0.020 |
Why?
|
| Carrier Proteins | 2 | 2001 | 4936 | 0.020 |
Why?
|
| Politics | 1 | 1997 | 815 | 0.020 |
Why?
|
| Autoradiography | 1 | 1991 | 728 | 0.020 |
Why?
|
| DNA Probes | 1 | 1991 | 541 | 0.020 |
Why?
|
| Edetic Acid | 1 | 2011 | 280 | 0.020 |
Why?
|
| Cell Line, Tumor | 3 | 2013 | 16981 | 0.020 |
Why?
|
| Matrix Metalloproteinase 7 | 1 | 2010 | 60 | 0.020 |
Why?
|
| Necrosis | 2 | 2010 | 1611 | 0.020 |
Why?
|
| Static Electricity | 1 | 2011 | 261 | 0.020 |
Why?
|
| Partial Pressure | 1 | 2010 | 245 | 0.020 |
Why?
|
| Chickens | 2 | 2010 | 859 | 0.020 |
Why?
|
| Polystyrenes | 1 | 2010 | 104 | 0.020 |
Why?
|
| HLA-DQ Antigens | 1 | 2010 | 191 | 0.020 |
Why?
|
| Diagnostic Imaging | 1 | 2004 | 3530 | 0.020 |
Why?
|
| Nucleic Acid Hybridization | 1 | 1991 | 1302 | 0.020 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2014 | 736 | 0.020 |
Why?
|
| Oxygen Consumption | 2 | 2011 | 1866 | 0.020 |
Why?
|
| Drug Combinations | 2 | 2010 | 2048 | 0.020 |
Why?
|
| Parenteral Nutrition, Total | 1 | 1990 | 304 | 0.020 |
Why?
|
| Herpes Simplex Virus Protein Vmw65 | 1 | 2009 | 27 | 0.020 |
Why?
|
| Proinsulin | 3 | 1985 | 135 | 0.020 |
Why?
|
| Collagenases | 1 | 2009 | 222 | 0.020 |
Why?
|
| Immune Tolerance | 2 | 2008 | 2303 | 0.020 |
Why?
|
| Infusions, Parenteral | 1 | 1989 | 397 | 0.020 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2001 | 4511 | 0.020 |
Why?
|
| Oleic Acid | 1 | 2008 | 92 | 0.020 |
Why?
|
| Tissue Preservation | 1 | 2009 | 174 | 0.020 |
Why?
|
| Histocompatibility Testing | 1 | 2010 | 712 | 0.020 |
Why?
|
| Temperature | 1 | 2014 | 2226 | 0.020 |
Why?
|
| Glycoproteins | 1 | 1995 | 2203 | 0.020 |
Why?
|
| Mitotic Index | 1 | 1988 | 162 | 0.020 |
Why?
|
| Finite Element Analysis | 1 | 2010 | 438 | 0.020 |
Why?
|
| Biological Assay | 1 | 2011 | 626 | 0.020 |
Why?
|
| Symporters | 1 | 2010 | 363 | 0.020 |
Why?
|
| Microscopy, Phase-Contrast | 1 | 1987 | 110 | 0.020 |
Why?
|
| Cytoprotection | 1 | 2008 | 200 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 4 | 2009 | 10766 | 0.020 |
Why?
|
| Fatty Acids, Monounsaturated | 1 | 2008 | 190 | 0.020 |
Why?
|
| Phosphorylation | 3 | 2007 | 8320 | 0.020 |
Why?
|
| Glutamine | 1 | 1990 | 577 | 0.020 |
Why?
|
| Materials Testing | 1 | 2011 | 863 | 0.020 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2009 | 411 | 0.020 |
Why?
|
| Nuclear Proteins | 2 | 2001 | 5796 | 0.020 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 1 | 1 | 2007 | 96 | 0.020 |
Why?
|
| Collagen | 2 | 2010 | 2638 | 0.020 |
Why?
|
| Antigens, CD | 3 | 2004 | 4003 | 0.020 |
Why?
|
| Microbial Collagenase | 1 | 1987 | 112 | 0.020 |
Why?
|
| Heterozygote | 3 | 1998 | 2787 | 0.020 |
Why?
|
| Potassium Channels, Inwardly Rectifying | 1 | 2007 | 144 | 0.020 |
Why?
|
| Swine, Miniature | 1 | 2009 | 961 | 0.020 |
Why?
|
| Interleukin-15 | 1 | 2007 | 185 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 2 | 2005 | 2645 | 0.020 |
Why?
|
| Pancreatitis | 1 | 2013 | 1096 | 0.020 |
Why?
|
| Membranes, Artificial | 2 | 1999 | 366 | 0.020 |
Why?
|
| Fibronectins | 1 | 2010 | 723 | 0.020 |
Why?
|
| alpha-Fetoproteins | 1 | 2007 | 223 | 0.020 |
Why?
|
| Analysis of Variance | 2 | 2010 | 6228 | 0.020 |
Why?
|
| Adenosine Triphosphate | 2 | 2003 | 1989 | 0.020 |
Why?
|
| Dumping Syndrome | 1 | 2005 | 18 | 0.020 |
Why?
|
| Enzyme Activation | 2 | 2002 | 3597 | 0.020 |
Why?
|
| Ischemia | 1 | 2014 | 1882 | 0.020 |
Why?
|
| Diazoxide | 1 | 2005 | 52 | 0.020 |
Why?
|
| Polyvinyl Alcohol | 2 | 1996 | 73 | 0.020 |
Why?
|
| Organ Specificity | 1 | 2010 | 1967 | 0.020 |
Why?
|
| Glucose Transporter Type 4 | 2 | 1996 | 240 | 0.020 |
Why?
|
| Pinocytosis | 1 | 2005 | 62 | 0.020 |
Why?
|
| Mice, Obese | 2 | 2000 | 420 | 0.020 |
Why?
|
| Culture Media | 2 | 2001 | 897 | 0.020 |
Why?
|
| Drug Synergism | 2 | 1989 | 1755 | 0.020 |
Why?
|
| Fluorocarbons | 1 | 2011 | 492 | 0.020 |
Why?
|
| Molecular Probe Techniques | 1 | 2006 | 111 | 0.020 |
Why?
|
| Body Mass Index | 1 | 2003 | 12953 | 0.020 |
Why?
|
| Annexin A5 | 1 | 2005 | 103 | 0.020 |
Why?
|
| Extracellular Matrix | 1 | 1993 | 1726 | 0.020 |
Why?
|
| Ferrosoferric Oxide | 1 | 2006 | 348 | 0.020 |
Why?
|
| Collagen Type IV | 1 | 2005 | 126 | 0.020 |
Why?
|
| Carbocyanines | 1 | 2005 | 175 | 0.020 |
Why?
|
| Homozygote | 2 | 2001 | 1776 | 0.020 |
Why?
|
| Epigenomics | 1 | 2010 | 943 | 0.010 |
Why?
|
| Oxides | 1 | 2006 | 401 | 0.010 |
Why?
|
| Octreotide | 1 | 2005 | 153 | 0.010 |
Why?
|
| Mutation | 1 | 2009 | 30052 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factor A | 3 | 2001 | 3492 | 0.010 |
Why?
|
| Magnetite Nanoparticles | 1 | 2006 | 318 | 0.010 |
Why?
|
| Polyglycolic Acid | 2 | 1996 | 406 | 0.010 |
Why?
|
| Diet Therapy | 1 | 2005 | 151 | 0.010 |
Why?
|
| Family Health | 1 | 2009 | 1257 | 0.010 |
Why?
|
| Dextrans | 1 | 2006 | 574 | 0.010 |
Why?
|
| Membrane Microdomains | 1 | 2005 | 206 | 0.010 |
Why?
|
| Chronic Disease | 5 | 2002 | 9318 | 0.010 |
Why?
|
| Intercellular Junctions | 2 | 1986 | 195 | 0.010 |
Why?
|
| Infrared Rays | 1 | 2005 | 247 | 0.010 |
Why?
|
| T-Lymphocytes | 2 | 2008 | 10194 | 0.010 |
Why?
|
| Mice, Mutant Strains | 2 | 2001 | 1749 | 0.010 |
Why?
|
| Rats, Mutant Strains | 1 | 2003 | 60 | 0.010 |
Why?
|
| Transplantation, Autologous | 1 | 2009 | 2115 | 0.010 |
Why?
|
| Serum Albumin | 1 | 2007 | 672 | 0.010 |
Why?
|
| Dogs | 1 | 1988 | 3839 | 0.010 |
Why?
|
| Perfusion | 3 | 1998 | 1373 | 0.010 |
Why?
|
| Glucose-6-Phosphatase | 1 | 2003 | 72 | 0.010 |
Why?
|
| Fasting | 2 | 2001 | 1603 | 0.010 |
Why?
|
| Exons | 1 | 2009 | 2391 | 0.010 |
Why?
|
| Cell Adhesion | 1 | 2010 | 3087 | 0.010 |
Why?
|
| Cysteine Endopeptidases | 1 | 2006 | 551 | 0.010 |
Why?
|
| Renin-Angiotensin System | 1 | 2008 | 737 | 0.010 |
Why?
|
| Weight Gain | 1 | 2013 | 2348 | 0.010 |
Why?
|
| Clodronic Acid | 1 | 2003 | 59 | 0.010 |
Why?
|
| Actins | 1 | 2010 | 2050 | 0.010 |
Why?
|
| Albumins | 1 | 2005 | 575 | 0.010 |
Why?
|
| Luminescent Measurements | 1 | 2004 | 342 | 0.010 |
Why?
|
| Chemical Precipitation | 1 | 2002 | 175 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2009 | 3792 | 0.010 |
Why?
|
| Tissue and Organ Procurement | 1 | 2010 | 961 | 0.010 |
Why?
|
| Cell Cycle | 1 | 2010 | 2932 | 0.010 |
Why?
|
| Electrophoresis | 1 | 2002 | 227 | 0.010 |
Why?
|
| Tolbutamide | 1 | 1981 | 23 | 0.010 |
Why?
|
| Glutamine-Fructose-6-Phosphate Transaminase (Isomerizing) | 1 | 2001 | 11 | 0.010 |
Why?
|
| 3T3 Cells | 1 | 2003 | 1085 | 0.010 |
Why?
|
| Infusion Pumps, Implantable | 1 | 2002 | 158 | 0.010 |
Why?
|
| Activating Transcription Factors | 1 | 2001 | 30 | 0.010 |
Why?
|
| Pedigree | 1 | 2009 | 4542 | 0.010 |
Why?
|
| Genes, bcl-2 | 1 | 2001 | 119 | 0.010 |
Why?
|
| Nonmuscle Myosin Type IIB | 1 | 2001 | 21 | 0.010 |
Why?
|
| Acyl-CoA Oxidase | 1 | 2001 | 8 | 0.010 |
Why?
|
| Transcription Factor CHOP | 1 | 2001 | 68 | 0.010 |
Why?
|
| Theophylline | 1 | 1981 | 131 | 0.010 |
Why?
|
| Myocytes, Cardiac | 1 | 2010 | 1668 | 0.010 |
Why?
|
| Isoproterenol | 1 | 1981 | 395 | 0.010 |
Why?
|
| Tomography, Emission-Computed | 1 | 2004 | 1122 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 3 | 2001 | 9177 | 0.010 |
Why?
|
| Carnitine O-Palmitoyltransferase | 1 | 2001 | 82 | 0.010 |
Why?
|
| DNA Mutational Analysis | 1 | 2009 | 4111 | 0.010 |
Why?
|
| Transcription Factor RelA | 1 | 2002 | 254 | 0.010 |
Why?
|
| RNA Interference | 1 | 2009 | 2831 | 0.010 |
Why?
|
| Insulin Infusion Systems | 1 | 2002 | 217 | 0.010 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 1982 | 945 | 0.010 |
Why?
|
| Interleukin-2 | 1 | 2007 | 1889 | 0.010 |
Why?
|
| APUD Cells | 1 | 1980 | 5 | 0.010 |
Why?
|
| Receptors, Urokinase Plasminogen Activator | 1 | 2000 | 75 | 0.010 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2002 | 441 | 0.010 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2002 | 517 | 0.010 |
Why?
|
| Hypoxia-Inducible Factor 1 | 1 | 2001 | 193 | 0.010 |
Why?
|
| Gluconeogenesis | 1 | 2001 | 185 | 0.010 |
Why?
|
| Sirolimus | 1 | 2007 | 1533 | 0.010 |
Why?
|
| Nephrectomy | 1 | 2005 | 937 | 0.010 |
Why?
|
| Keratin-7 | 1 | 1999 | 55 | 0.010 |
Why?
|
| Linear Models | 1 | 2010 | 5871 | 0.010 |
Why?
|
| Structure-Activity Relationship | 1 | 2005 | 3076 | 0.010 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 1 | 2001 | 286 | 0.010 |
Why?
|
| Ganglia | 1 | 1980 | 87 | 0.010 |
Why?
|
| Pancreatic Hormones | 1 | 1999 | 12 | 0.010 |
Why?
|
| Reptiles | 1 | 1979 | 9 | 0.010 |
Why?
|
| Follow-Up Studies | 2 | 2019 | 39106 | 0.010 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2001 | 2872 | 0.010 |
Why?
|
| Lipids | 2 | 2008 | 3341 | 0.010 |
Why?
|
| Neuroendocrine Secretory Protein 7B2 | 1 | 1999 | 2 | 0.010 |
Why?
|
| Proprotein Convertase 2 | 1 | 1999 | 11 | 0.010 |
Why?
|
| Amphibians | 1 | 1979 | 29 | 0.010 |
Why?
|
| Receptor, Cholecystokinin A | 1 | 1999 | 13 | 0.010 |
Why?
|
| Myosin Heavy Chains | 1 | 2001 | 405 | 0.010 |
Why?
|
| Lac Operon | 1 | 1999 | 237 | 0.010 |
Why?
|
| Lipolysis | 1 | 2000 | 212 | 0.010 |
Why?
|
| Liposomes | 1 | 2003 | 784 | 0.010 |
Why?
|
| Niacinamide | 1 | 2001 | 413 | 0.010 |
Why?
|
| Biocompatible Materials | 2 | 1998 | 1685 | 0.010 |
Why?
|
| Nitric Oxide Synthase | 1 | 2002 | 908 | 0.010 |
Why?
|
| Macrophages | 1 | 1994 | 5769 | 0.010 |
Why?
|
| Phenotype | 2 | 2010 | 16591 | 0.010 |
Why?
|
| Hepatocyte Nuclear Factor 1 | 1 | 1998 | 27 | 0.010 |
Why?
|
| Pro-Opiomelanocortin | 1 | 1999 | 140 | 0.010 |
Why?
|
| Cholecystokinin | 1 | 1999 | 117 | 0.010 |
Why?
|
| Birds | 1 | 1979 | 168 | 0.010 |
Why?
|
| Fatty Acid-Binding Proteins | 1 | 2000 | 296 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2005 | 3810 | 0.010 |
Why?
|
| Antigens, Differentiation, B-Lymphocyte | 1 | 1999 | 317 | 0.010 |
Why?
|
| Light | 1 | 2004 | 1353 | 0.010 |
Why?
|
| Golgi Apparatus | 1 | 1980 | 405 | 0.010 |
Why?
|
| Fat Emulsions, Intravenous | 1 | 2001 | 314 | 0.010 |
Why?
|
| Glycosylation | 1 | 2001 | 1098 | 0.010 |
Why?
|
| Injections, Intramuscular | 1 | 1999 | 554 | 0.010 |
Why?
|
| Iron | 1 | 2006 | 1793 | 0.010 |
Why?
|
| Fluorescent Dyes | 1 | 2006 | 1903 | 0.010 |
Why?
|
| Gene Transfer Techniques | 1 | 2003 | 1206 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-1 | 1 | 2001 | 558 | 0.010 |
Why?
|
| Lymphocyte Activation | 1 | 2008 | 5486 | 0.010 |
Why?
|
| Receptors, Vascular Endothelial Growth Factor | 1 | 2001 | 664 | 0.010 |
Why?
|
| RNA, Small Interfering | 1 | 2006 | 3429 | 0.010 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 1999 | 393 | 0.010 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2001 | 1693 | 0.010 |
Why?
|
| Immunoglobulin Fc Fragments | 1 | 1999 | 280 | 0.010 |
Why?
|
| Treatment Outcome | 3 | 2013 | 64680 | 0.010 |
Why?
|
| Hepatocyte Nuclear Factor 1-alpha | 1 | 1998 | 174 | 0.010 |
Why?
|
| Protein Folding | 1 | 2001 | 870 | 0.010 |
Why?
|
| Cytoplasmic Granules | 1 | 1980 | 574 | 0.010 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2001 | 619 | 0.010 |
Why?
|
| Phantoms, Imaging | 1 | 2005 | 2526 | 0.010 |
Why?
|
| Lymph Nodes | 1 | 2008 | 3466 | 0.010 |
Why?
|
| Child | 2 | 2019 | 80153 | 0.010 |
Why?
|
| Nerve Growth Factors | 1 | 1980 | 564 | 0.010 |
Why?
|
| Glomerular Filtration Rate | 1 | 2005 | 2176 | 0.010 |
Why?
|
| Islet Amyloid Polypeptide | 1 | 1996 | 42 | 0.010 |
Why?
|
| Cadherins | 1 | 2001 | 903 | 0.010 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2001 | 857 | 0.010 |
Why?
|
| Infusions, Intravenous | 1 | 2001 | 2219 | 0.010 |
Why?
|
| Aged, 80 and over | 2 | 2017 | 58976 | 0.010 |
Why?
|
| Mutagenesis, Insertional | 1 | 1999 | 656 | 0.010 |
Why?
|
| Cholesterol | 1 | 2005 | 2904 | 0.010 |
Why?
|
| Death | 1 | 2001 | 676 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-met | 1 | 2000 | 571 | 0.010 |
Why?
|
| B-Lymphocytes | 1 | 2009 | 4758 | 0.010 |
Why?
|
| Postoperative Period | 1 | 2001 | 1813 | 0.010 |
Why?
|
| Microscopy, Immunoelectron | 1 | 1996 | 317 | 0.010 |
Why?
|
| Blood Proteins | 1 | 2001 | 1173 | 0.010 |
Why?
|
| Fishes | 1 | 1979 | 603 | 0.010 |
Why?
|
| Action Potentials | 1 | 2003 | 1834 | 0.010 |
Why?
|
| Peritoneal Cavity | 1 | 1995 | 135 | 0.010 |
Why?
|
| Lithostathine | 1 | 1994 | 5 | 0.010 |
Why?
|
| Mice, Inbred DBA | 1 | 1996 | 621 | 0.010 |
Why?
|
| Densitometry | 1 | 1995 | 151 | 0.010 |
Why?
|
| Epididymis | 1 | 1996 | 228 | 0.010 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 1999 | 1435 | 0.010 |
Why?
|
| MicroRNAs | 1 | 2010 | 3816 | 0.010 |
Why?
|
| Gene Targeting | 1 | 1998 | 838 | 0.010 |
Why?
|
| Fetal Blood | 1 | 2001 | 1347 | 0.010 |
Why?
|
| Nanoparticles | 1 | 2006 | 1959 | 0.010 |
Why?
|
| Genetic Markers | 1 | 2000 | 2601 | 0.010 |
Why?
|
| Point Mutation | 1 | 1999 | 1595 | 0.010 |
Why?
|
| Free Radicals | 1 | 1994 | 238 | 0.010 |
Why?
|
| Diabetic Ketoacidosis | 1 | 1997 | 253 | 0.010 |
Why?
|
| Connective Tissue | 1 | 1995 | 419 | 0.010 |
Why?
|
| Catalase | 1 | 1994 | 218 | 0.010 |
Why?
|
| Evaluation Studies as Topic | 1 | 1995 | 1624 | 0.010 |
Why?
|
| Contrast Media | 1 | 2006 | 5311 | 0.010 |
Why?
|
| Recombination, Genetic | 1 | 1998 | 1519 | 0.010 |
Why?
|
| Free Radical Scavengers | 1 | 1994 | 211 | 0.010 |
Why?
|
| Cytokines | 1 | 2008 | 7396 | 0.010 |
Why?
|
| Germ-Line Mutation | 1 | 2001 | 1858 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 1994 | 1545 | 0.010 |
Why?
|
| Cohort Studies | 2 | 2010 | 41487 | 0.010 |
Why?
|
| Glucocorticoids | 1 | 2002 | 2161 | 0.010 |
Why?
|
| Leptin | 1 | 2000 | 1597 | 0.010 |
Why?
|
| Age Factors | 1 | 2009 | 18395 | 0.010 |
Why?
|
| Biological Transport | 1 | 1996 | 2091 | 0.010 |
Why?
|
| Superoxide Dismutase | 1 | 1994 | 594 | 0.010 |
Why?
|
| Protein Processing, Post-Translational | 1 | 1999 | 1974 | 0.010 |
Why?
|
| Immunoglobulin G | 1 | 2003 | 4544 | 0.010 |
Why?
|
| Endothelium, Corneal | 1 | 1993 | 215 | 0.010 |
Why?
|
| Trypsinogen | 1 | 1990 | 84 | 0.010 |
Why?
|
| Models, Cardiovascular | 1 | 1996 | 981 | 0.010 |
Why?
|
| Phosphotyrosine | 1 | 1991 | 456 | 0.010 |
Why?
|
| Interleukin-1 | 1 | 1994 | 1248 | 0.010 |
Why?
|
| Papio | 1 | 1991 | 669 | 0.010 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 1991 | 329 | 0.010 |
Why?
|
| Cell Movement | 1 | 2001 | 5203 | 0.010 |
Why?
|
| Nitrogen | 1 | 1990 | 348 | 0.000 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 1998 | 2865 | 0.000 |
Why?
|
| Myocardium | 1 | 2001 | 4726 | 0.000 |
Why?
|
| Lipase | 1 | 1990 | 325 | 0.000 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2009 | 17904 | 0.000 |
Why?
|
| Cytoplasm | 1 | 1992 | 1510 | 0.000 |
Why?
|
| Drinking | 1 | 1988 | 198 | 0.000 |
Why?
|
| Immunoglobulin M | 1 | 1992 | 1527 | 0.000 |
Why?
|
| Child, Preschool | 1 | 2010 | 42230 | 0.000 |
Why?
|
| Sex Factors | 1 | 1981 | 10552 | 0.000 |
Why?
|
| Tyrosine | 1 | 1991 | 1440 | 0.000 |
Why?
|
| Mitochondria | 1 | 1980 | 3624 | 0.000 |
Why?
|
| Alleles | 1 | 1997 | 6863 | 0.000 |
Why?
|
| Acute Disease | 1 | 1996 | 7237 | 0.000 |
Why?
|
| Atrophy | 1 | 1990 | 1633 | 0.000 |
Why?
|
| Calcium | 1 | 1998 | 5722 | 0.000 |
Why?
|
| Injections, Intravenous | 1 | 1987 | 1379 | 0.000 |
Why?
|
| Castration | 1 | 1984 | 151 | 0.000 |
Why?
|
| Radioimmunoassay | 1 | 1984 | 862 | 0.000 |
Why?
|
| Incidence | 1 | 2001 | 21353 | 0.000 |
Why?
|
| Veins | 1 | 1987 | 768 | 0.000 |
Why?
|
| Skin | 1 | 1996 | 4484 | 0.000 |
Why?
|
| Genotype | 1 | 1997 | 12990 | 0.000 |
Why?
|
| Autoimmune Diseases | 1 | 1994 | 2244 | 0.000 |
Why?
|
| Autonomic Nervous System | 1 | 1986 | 703 | 0.000 |
Why?
|
| Immune Sera | 1 | 1980 | 606 | 0.000 |
Why?
|
| Intestinal Mucosa | 1 | 1990 | 3032 | 0.000 |
Why?
|
| Neural Crest | 1 | 1980 | 279 | 0.000 |
Why?
|
| Immunization, Passive | 1 | 1980 | 616 | 0.000 |
Why?
|
| Amino Acids | 1 | 1983 | 1718 | 0.000 |
Why?
|
| Antibodies | 1 | 1982 | 2418 | 0.000 |
Why?
|
| Prognosis | 1 | 1992 | 29625 | 0.000 |
Why?
|
| Prospective Studies | 1 | 1992 | 54425 | 0.000 |
Why?
|